After FDA Approval, Drugmakers Often Miss Study Mark

After FDA Approval, Drugmakers Often Miss Study Mark

For starters, before the FDA got new powers there were over a thousand studies — more than half of those the agency expected to be performed— that hadn't been started by drugmakers. That number fell to 775 studies, or about 44 percent, in 2011. Progress.

3
Like
Save

Comments

Write a comment

*